 |
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
|
||||
 |
|
||||||||||
|
Pooled technology and joint research Optimised capitalisation on development and technology through joint research or joint acquisition between the partners is another advantage. EURALLIANCE FARMA is able to keep R&D budgets to a minimum by avoiding the expensive individual development of products. R&D becomes more productive, faster and more innovative, at lower cost. EURALLIANCE FARMA partners enjoy access to proven technology and new opportunities in licensing, acquisition, and investment, which would otherwise be inaccessible and financially not viable. Member companies are then able to work with multinational organisations to provide tailored solutions to local issues and market needs.
Our
philosophy | Our
strenghts | Our
Services | Members |  |
 |
|
|||||||||
 |
|
||||||||||
 |
|
||||||||||
 |
|
||||||||||
 |
|
||||||||||
 |
|
||||||||||
 |
|
||||||||||
 |
|
||||||||||
 |
|
||||||||||
 |
|
||||||||||
|
|||||||||||
|
|||||||||||
|
|||||||||||